Messaged Sam regarding world first and media exposure and recived this reply with in 15 mins.
Sam has always responded to any of my emails with in a couple of hrs.
Dear ,It is a "world first" in that it is the first drug focused on regenerating synapses.MPL is different in that it could potentially reduce the rate of degeneration and loss of motor neurons in the anterior horns and motor nuclei of the brainstem.I suspect that both drugs could be used in combination as could many of the other treatments currently in development.PAA has sought and received media exposure.Thanks for your enquiry.
Ann: Epichem enters voluntary liquidation, page-150
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
-0.010(5.41%) |
Mkt cap ! $69.28M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 17.5¢ | $58.74K | 325.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 270003 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 116651 | 3 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
18.0¢ |
Change
-0.010 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 18.0¢ | 18.0¢ | 17.5¢ | 141605 | ||
| Last updated 15.28pm 21/05/2024 ? | |||||
| PAA (ASX) Chart |